| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers O > Headlines for OraSure Technologies, Inc. > News item |
CDC commits to bulk purchase of OraSure's OraQuick Advance tests for HIV prevention programs
By E. Janene Geiss
Philadelphia, May 18 - OraSure Technologies, Inc. announced Thursday that The Centers for Disease Control and Prevention has provided the company with a purchase order for the immediate bulk procurement of its OraQuick Advance Rapid HIV-½ antibody test.
The CDC placed the order to further support its prevention initiatives. This order is the fourth bulk purchase of OraQuick devices made by the CDC since the initiative was launched in 2003, according to a company news release.
"OraSure's rapid HIV test plays a critical role in complementing our public health strategies for prevention initiatives and efforts to expand access to quality health care and services for those who need them," Sen. Rick Santorum, R-Pa., said in the release.
This latest bulk purchase order placed by the CDC is for $2.3 million and is expected to be fully deployed in 2006, officials said.
This order is in response to a growing demand in the U.S. public health market for oral fluid rapid HIV testing.
The company said it believes this demand for tests is well in excess of the quantity covered by the CDC's latest bulk purchase.
As a result, OraSure said it is continuing discussions with federal agencies regarding additional purchases this year.
These discussions are separate from the company's ongoing discussions regarding orders by several cities that have indicated an intent to substantially increase their HIV testing efforts, officials said.
As a result of the CDC order, the company said it now projects total revenues of $80 million and net income in the range of $0.10 to $0.12 per share for the full-year 2006.
OraSure, based in Bethlehem, Pa., makes oral fluid specimen collection devices and tests and other diagnostic products.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.